comparemela.com
Home
Live Updates
Vikram Paradkar - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Vikram paradkar - Page 1 : comparemela.com
Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod
As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.
Patna
Bihar
India
Hyderabad
Andhra-pradesh
Wuhan
Hubei
China
Vikram-paradkar
Sohini-das
Linda-geddes
Serum-institute-of-india
COVID-19 - Biological E, Bharat Biotech together sitting on stockpile of 250 million Covid-19 vaccine doses
According to respective company sources, 200 million doses of Corbevax while 50 million doses of Covaxin are ready to dispatch as and when orders are received
Houston
Texas
United-states
India
Bharat
Vikram-paradkar
Texas-children-hospital-center
National-institute-of-virology
Indian-council-of-medical-research
Vaccine-development-texas-children
Baylor-college-of-medicine
Executive-vice-president
Biological E to test COVID-19 vaccine Corbevax on infants as young as six months
The vaccine is found safe & immunogenic in 5-18 age group
Hyderabad
Andhra-pradesh
India
Vikram-paradkar
Executive-vice-president-technical-operations
Vaccine
Covid-19
Biological-e
Centre approves Corbevax as precautionary dose for adults jabbed with Covishield, Covaxin
In June, the Drugs Controller General of India had approved Corbevax as the first mix-and-match booster dose in the country.
Hyderabad
Andhra-pradesh
India
Vikram-paradkar
Rajesh-bhushan
Union-territories
Serum-institute-covishield-or-bharat-biotech-covaxin
Centre-on
Union-health
World-health-organization
National-technical-advisory-group-on-immunisation
Serum-institute
Is it time to overhaul India's Covid vaccination policy? Experts answer
Experts say India’s Covid-19 vaccine policy needs an overhaul to keep up with new data and new variants of coronavirus.
India
Kolkata
West-bengal
Vellore
Tamil-nadu
Canada
Israel
Israeli
Gautam-menon
Giridhara-babu
Vikram-paradkar
Piyush-goyal
vimarsana © 2020. All Rights Reserved.